5:42 PM
 | 
May 29, 2008
 |  BC Extra  |  Top Story

Bristol-Myers to acquire Kosan

Bristol-Myers (NYSE:BMY) said it will acquire cancer company Kosan (NASDAQ:KOSN) in a tender offer for $5.50 per share, or about $234.6 million in cash. The price is a 233% premium to Kosan's close of $1.65 on Wednesday, before the...

Read the full 184 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >